TY - JOUR
T1 - Interventional Cardio-Oncology
T2 - Adding a New Dimension to the Cardio-Oncology Field
AU - Liu, Victor Y.
AU - Agha, Ali M.
AU - Lopez-Mattei, Juan
AU - Palaskas, Nicolas
AU - Kim, Peter
AU - Thompson, Kara
AU - Mouhayar, Elie
AU - Marmagkiolis, Konstantinos
AU - Hassan, Saamir A.
AU - Karimzad, Kaveh
AU - Iliescu, Cezar A.
N1 - Publisher Copyright:
© Copyright © 2018 Liu, Agha, Lopez-Mattei, Palaskas, Kim, Thompson, Mouhayar, Marmagkiolis, Hassan, Karimzad and Iliescu.
PY - 2018/5/17
Y1 - 2018/5/17
N2 - The management of cardiovascular disease in patients with active cancer presents a unique challenge in interventional cardiology. Cancer patients often suffer from significant comorbidities such as thrombocytopenia and coagulopathic and/or hypercoagulable states, which complicates invasive evaluation and can specifically be associated with an increased risk for vascular access complications. Furthermore, anticancer therapies cause injury to the vascular endothelium as well as the myocardium. Meanwhile, improvements in diagnosis and treatment of various cancers have contributed to an increase in overall survival rates in cancer patients. Proper management of this patient population is unclear, as cancer patients are largely excluded from randomized clinical trials on percutaneous coronary intervention (PCI) and national PCI registries. In this review, we will discuss the role of different safety measures that can be applied prior to and during these invasive cardiovascular procedures as well as the role of intravascular imaging techniques in managing these high risk patients.
AB - The management of cardiovascular disease in patients with active cancer presents a unique challenge in interventional cardiology. Cancer patients often suffer from significant comorbidities such as thrombocytopenia and coagulopathic and/or hypercoagulable states, which complicates invasive evaluation and can specifically be associated with an increased risk for vascular access complications. Furthermore, anticancer therapies cause injury to the vascular endothelium as well as the myocardium. Meanwhile, improvements in diagnosis and treatment of various cancers have contributed to an increase in overall survival rates in cancer patients. Proper management of this patient population is unclear, as cancer patients are largely excluded from randomized clinical trials on percutaneous coronary intervention (PCI) and national PCI registries. In this review, we will discuss the role of different safety measures that can be applied prior to and during these invasive cardiovascular procedures as well as the role of intravascular imaging techniques in managing these high risk patients.
KW - fractional flow reserve
KW - instantaneous free-wave ratio
KW - interventional cardio-oncology
KW - intravascular imaging
KW - optical coherence tomography
KW - takotsubo cardiomyopathy
KW - thrombocytopenia
KW - transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85054186226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054186226&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2018.00048
DO - 10.3389/fcvm.2018.00048
M3 - Review article
C2 - 29868614
AN - SCOPUS:85054186226
SN - 2297-055X
VL - 5
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 48
ER -